Durvalumab and tremelimumab for hepatocellular carcinoma in patients listed for a liver transplant.

被引:0
|
作者
Sohal, Davendra
Moreland, Katie
Quillin, Ralph
Lemon, Kristina
Rojan, Adam
Olowokure, Olugbenga Olanrele
Shah, Shimul
机构
[1] Univ Cincinnati, Cincinnati, OH USA
[2] Univ Cincinnati, Coll Med, Cincinnati, OH USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TPS638
引用
收藏
页码:TPS638 / TPS638
页数:1
相关论文
共 50 条
  • [21] Incidental Hepatocellular Carcinoma Bony Metastasis in a Patient Listed for Liver Transplant
    Levine, Jake W.
    Hawa, Fadi
    Bloom, Patricia P.
    [J]. ACG CASE REPORTS JOURNAL, 2023, 10 (01)
  • [22] New drugs approval: Durvalumab and tremelimumab as first line in the unresecable hepatocellular carcinoma
    Pureur, Dimitri
    Edeline, Julien
    [J]. BULLETIN DU CANCER, 2023, 110 (7-8) : 741 - 742
  • [23] Phase 1/2 study of durvalumab and tremelimumab as monotherapy and in combination in patients with unresectable hepatocellular carcinoma (HCC)
    Abou-Alfa, Ghassan K.
    Sangro, Bruno
    Morse, Michael
    Zhu, Andrew X.
    Kim, Richard D.
    Cheng, Ann-Lii
    Kudo, Masatoshi
    Kang, Yoon-Koo
    Chan, Stephen L.
    Antal, Joyce
    Boice, Jillian
    Xiao, Feng
    Morris, Shannon R.
    Bendell, Johanna
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [24] Prognostic factors for patients with recurrent hepatocellular carcinoma following liver transplant. A Euro-American study
    Sapisochin, Gonzalo
    Goldaracena, Nicolas
    Astete, Santiago
    Davidson, Duncan
    Ehab, Rafael
    Castells, Lluis
    Sandroussi, Charbel
    Bilbao, Itxarone
    Lilly, Les
    Dopazo, Cristina
    Ghanekar, Anand
    McGilvray, Ian
    Cattral, Mark
    Selzner, Markus
    Grant, David
    Charco, Ramon
    Greig, Paul
    [J]. HEPATOLOGY, 2014, 60 : 854A - 854A
  • [25] Tremelimumab (day 1 only) and durvalumab in combination with transarterial chemoemobilization (TACE) in patients with hepatocellular carcinoma (HCC)
    Buchalter, Jemma
    Browne, Iseult
    Mac Eochagain, Colm
    Flynn, Calvin
    Carroll, Hailey Kathryn
    Galligan, Marie
    Bourke, Michele
    Lester-Grant, Amy
    Desmond, Fiona
    Hoey, Katherine
    Ryan, Ronan
    Cantwell, Colin P.
    McCann, Jeffrey
    McDermott, Ray
    MacNicholas, Ross
    Duffy, Austin G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [26] Tremelimumab (day 1 only) and durvalumab in combination with transarterial chemoemobilization (TACE) in patients with hepatocellular carcinoma (HCC).
    Buchalter, Jemma
    Evans, Niamh
    Browne, Iseult
    Mac Eochagain, Colm
    Flynn, Calvin
    Carroll, Hailey Kathryn
    Galligan, Marie
    Bourke, Michele
    Lester-Grant, Amy
    Hoey, Katherine
    Ryan, Ronan
    Cantwell, Colin P.
    McCann, Jeffrey
    McDermott, Ray
    MacNicholas, Ross
    Duffy, Austin G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16175 - E16175
  • [27] Prognostic Factors for Patients With Recurrent Hepatocellular Carcinoma Following Liver Transplant. A Euro-American Study
    Sapisochin, Gonzalo
    Goldaracena, Nicolas
    Astete, Santiago
    Laurence, Jerome
    Davidson, Duncan
    Rafael, Ehab
    Castells, Luis
    Sandroussi, Charbel
    Bilbao, Itxarone
    Dopazo, Cristina
    Grant, David
    Ghanekar, Anand
    McGilvray, Ian
    Cattral, Marc
    Selzner, Markus
    Charco, Ramon
    Greig, Paul
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 : 90 - 90
  • [28] LIVER TRANSPLANT ALLOCATION TO PATIENTS WITH HEPATOCELLULAR CARCINOMA
    Dawwas, Muhammad F.
    Watson, Christopher J.
    Gimson, Alexander E.
    [J]. HEPATOLOGY, 2008, 48 (04) : 351A - 351A
  • [29] Initial clinical experience with durvalumab plus tremelimumab in patients with unresectable hepatocellular carcinoma in real-world practice
    Shimose, Shigeo
    Saeki, Issei
    Tomonari, Tetsu
    Ito, Takanori
    Tani, Joji
    Takeuchi, Yasuto
    Yoshioka, Naoki
    Naito, Takehito
    Takeuchi, Mamiko
    Kakizaki, Satoru
    Hatanaka, Takeshi
    Sasaki, Kyo
    Yasunaka, Tetsuya
    Sakata, Masahiro
    Iwamoto, Hideki
    Itano, Satoshi
    Shirono, Tomotake
    Tanabe, Norikazu
    Yamamoto, Takafumi
    Naganuma, Atsushi
    Nishina, Soji
    Otsuka, Motoyuki
    Kawashima, Hiroki
    Takayama, Tetsuji
    Takami, Taro
    Kawaguchi, Takumi
    [J]. ONCOLOGY LETTERS, 2024, 28 (02)
  • [30] Symptomatic Hypogonadism in Patients listed for Liver Transplantation and Hepatocellular Carcinoma
    Waghray, Abhijeet
    Waghray, Nisheet
    Kyprianou, Annette
    Menon, K. V. Narayanan
    [J]. HEPATOLOGY, 2014, 60 : 965A - 966A